TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-6.78%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.35B
AUM Growth
+$2.35B
(-9.7%)
Cap. Flow
-$36.9M
Cap. Flow
% of AUM
-1.57%
Top 10 Holdings %
Top 10 Hldgs %
44.73%
Holding
156
New
14
Increased
27
Reduced
18
Closed
11
Top Buys
| 1 |
Biogen
BIIB
|
$15.7M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$12.3M |
| 3 |
Johnson & Johnson
JNJ
|
$12.2M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$10.6M |
| 5 |
CCP
Care Capital Properties, Inc.
CCP
|
$8.63M |
Top Sells
| 1 |
Alkermes
ALKS
|
$27.4M |
| 2 |
Agilent Technologies
A
|
$21.7M |
| 3 |
CPHD
Cepheid Inc
CPHD
|
$17.6M |
| 4 |
Eli Lilly
LLY
|
$16.2M |
| 5 |
UnitedHealth
UNH
|
$13.6M |
Sector Composition
| 1 | Healthcare | 90.58% |
| 2 | Real Estate | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Assertio
ASRT
$78M
| – | – |
-200,000
| Closed | -$5M |
|